An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers.

Breast Cancer Res Treat 2016 06 27;157(2):319-327. Epub 2016 Apr 27.

The High Risk Clinic, Meirav Center, Sheba Medical Center, Tel Hashomer, Israel.

Female BRCA1/BRCA2 mutation carriers are at substantially increased risk for developing breast and/or ovarian cancer, and are offered enhanced surveillance including screening from a young age and risk-reducing surgery (RRS)-mastectomy (RRM) and/or salpingo-oophorectomy (RRSO). While there are established guidelines for early detection of breast cancer in high-risk women who have not undergone RRM, there are less developed guidelines after RRM. We evaluated the schemes offered before and after RRS in internationally diverse high-risk clinics. An e-mailed survey was distributed to high-risk clinics affiliated with CIMBA. Overall, 22 centers from 16 countries responded. Pre RRS surveillance schemes overwhelmingly included breast imaging (primarily MRI) from 18 to 30 years and clinical breast exam (CBE) at 6-12 month intervals. For ovarian cancer, all but 6 centers offered semiannual/annual gynecological exam, transvaginal ultrasound, and CA 125 measurements. Post RRM, most centers offered only annual CBE while 4 centers offered annual MRI, primarily for substantial residual breast tissue. After RRSO only 4 centers offered specific gynecological surveillance. Existing guidelines for breast/ovarian cancer detection in BRCA carriers are being applied pre RRS but are not globally harmonized, and most centers offer no specific surveillance post RRS. From this comprehensive multinational study it is clear that evidence-based, long-term prospective data on the most effective scheme for BRCA carriers post RRS is needed.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3805-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508745PMC
June 2016
65 Reads

Publication Analysis

Top Keywords

centers offered
16
mutation carriers
8
post rrs
8
ovarian cancer
8
offered annual
8
surveillance schemes
8
pre rrs
8
high-risk clinics
8
brca carriers
8
offered
6
centers
6
breast
5
rrs
5
surveillance
5
cancer centers
4
6-12 month intervals
4
exam cbe
4
cbe 6-12 month
4
intervals ovarian
4
semiannual/annual gynecological
4

References

(Supplied by CrossRef)
Article in Ann Intern Med
HD Nelson et al.
Ann Intern Med 2014
Article in BMJ
AC Armstrong et al.
BMJ 2014
Article in BMC Women’s Health
C Marchetti et al.
BMC Women’s Health 2014
Article in Cancer
JL Walker et al.
Cancer 2015
Article in J Clin Oncol
JL Kramer et al.
J Clin Oncol 2005
Article in JAMA
SM Domchek et al.
JAMA 2010
Article in J Clin Oncol
AP Finch et al.
J Clin Oncol 2014
Article in J Natl Cancer
BA Heemskerk-Gerritsen et al.
J Natl Cancer 2015
Article in Ann Surg Oncol
S Pruthi et al.
Ann Surg Oncol 2015
Article in Breast Cancer Res Treat
X Chai et al.
Breast Cancer Res Treat 2014
Article in J Natl Cancer Inst
TR Rebbeck et al.
J Natl Cancer Inst 2009

Similar Publications